Study Identifies More Than a Dozen Existing Drugs as Potential COVID-19 Therapies
A researcher at Calibr, the drug discovery division of Scripps Research, working in the high-throughput screening facility used to identify potential COVID-19 therapies. Courtesy of Scripps Research Mining the world’s…